Pulmatrix, Inc.

PULM Nasdaq SEC CIK 1574235
Follow Pulmatrix Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$1.2M −38.3% vs same quarter last year
EPS, diluted −$0.34 −41.7% vs same quarter last year
Operating cash flow −$770K +25.3% vs same quarter last year
Operating income −$1.2M −41% vs same quarter last year
Net income by quarter
−$2M
−$1.8M
−$1.5M
−$877K
−$928K
−$1.2M
−$1M
−$1.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income13 fiscal years
  • Revenue
  • Net income
−$40M−$20M$0$20MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$5.2M
FY24$7.8M−$9.6M
FY23$7.3M−$14.1M
FY22$6.1M−$18.8M
FY21$5.2M−$20.2M
FY20$12.6M−$19.3M
FY19$7.9M−$20.6M
FY18$153K−$20.6M
FY17$335K−$18.1M
FY16$835K−$27.8M
FY15$1.2M−$26.2M
FY14$352K−$24.1M
FY13--
MarginsShare of revenue
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24−125.1%−122.5%
FY23−202%−193.5%
FY22−312.1%−310.3%
FY21−390.2%−390.2%
FY20−78.1%−152.8%
FY19−261.6%−260.4%
FY18−13333.3%−13439.9%
FY17−5216.4%−5389.9%
FY16−2978%−3334.5%
FY15−1916.6%−2178.8%
FY14−2578.4%−6859.1%
FY13--
Free cash flowOperating cash flow minus capital expenditure
−$20M−$10M$0$10MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$11.1M
FY23−$16.7M
FY22−$19.4M
FY21−$19.9M
FY20−$12.8M
FY19$3.2M
FY18−$16.8M
FY17−$14.6M
FY16−$13.7M
FY15−$12.7M
FY14−$9.5M
FY13-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Pulmatrix
  • Healthcare median
−15000%−10000%−5000%0%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPulmatrixHealthcare median
FY25-−30.6%
FY24−122.5%−47%
FY23−193.5%−58%
FY22−310.3%−80.4%
FY21−390.2%−71.8%
FY20−152.8%−62.2%
FY19−260.4%−46.2%
FY18−13439.9%−49.6%
FY17−5389.9%−45.9%
FY16−3334.5%−36%
FY15−2178.8%−37.8%
FY14−6859.1%−35.5%
FY13-−37.1%